About Nightstar
Nightstar is a company based in London (United Kingdom) founded in 2013 was acquired by Biogen in March 2019.. Nightstar has raised $99.88 million across 3 funding rounds from investors including Biogen, Syncona and Imperial Innovations. The company has 15 employees as of December 31, 2021. Nightstar offers products and services including Alzheimer's Therapies, Multiple Sclerosis Medicines, and Spinal Muscular Atrophy Treatments. Nightstar operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter London, United Kingdom
- Employees 15 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nightstarx Limited
- Date of Incorporation 31 May, 2013
- Jurisdiction MAIDENHEAD, BERKSHIRE, ENGLAND
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nightstar
Nightstar offers a comprehensive portfolio of products and services, including Alzheimer's Therapies, Multiple Sclerosis Medicines, and Spinal Muscular Atrophy Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments targeting neurological disorders like Alzheimer's.
Therapies for managing multiple sclerosis symptoms.
Medications for rare genetic disorders affecting muscles.
Funding Insights of Nightstar
Nightstar has successfully raised a total of $99.88M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $45 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $45.0M
-
First Round
First Round
(30 Jan 2014)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2017 | Amount | Series C - Nightstar | Valuation |
investors |
|
| Nov, 2015 | Amount | Series B - Nightstar | Valuation | New Enterprise Associates |
|
| Jan, 2014 | Amount | Series A - Nightstar | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nightstar
Nightstar has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Biogen, Syncona and Imperial Innovations. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are managed via private equity by Syncona.
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Investments in startups are focused on Europe and the US.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nightstar
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nightstar
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nightstar Comparisons
Competitors of Nightstar
Nightstar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nightstar
Frequently Asked Questions about Nightstar
When was Nightstar founded?
Nightstar was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Nightstar located?
Nightstar is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of Nightstar?
Dave Fellows is the current CEO of Nightstar.
Is Nightstar a funded company?
Nightstar is a funded company, having raised a total of $99.88M across 3 funding rounds to date. The company's 1st funding round was a Series A of $19.88M, raised on Jan 30, 2014.
How many employees does Nightstar have?
As of Dec 31, 2021, the latest employee count at Nightstar is 15.
What does Nightstar do?
Nightstar was founded in 2013 in London, United Kingdom, within the biotechnology sector focused on gene therapy. Retinal disorders are addressed through candidates such as NSR-REP1, designated as an orphan drug by the FDA and EMA for choroideremia, NSR-RPGR in Phase 12 trials for X-linked retinitis pigmentosa, and NSR-BEST1 under preclinical evaluation for Best vitelliform macular dystrophy. Operations center on advancing these therapies for rare genetic conditions.
Who are the top competitors of Nightstar?
Nightstar's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Nightstar offer?
Nightstar offers Alzheimer's Therapies, Multiple Sclerosis Medicines, and Spinal Muscular Atrophy Treatments.
Who are Nightstar's investors?
Nightstar has 6 investors. Key investors include Biogen, Syncona, Imperial Innovations, Wellington, and NEA.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.